NeuroSense Announces Pre-NDS Meeting With Health Canada Rescheduled To May 2026 To Gather Additional Clinical Data For PrimeC Lead Candidate; Expects To Report Clinical Results From Alzheimer's Study In Coming Weeks

Benzinga Newsdesk www.benzinga.com Neutral 72.7%

Neg 0% Neu 72.7% Pos 0%

Comments

No comments yet. Be the first!